NIBEC Co., Ltd. (KOSDAQ:138610)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,250
-600 (-2.23%)
At close: Jun 26, 2025, 3:30 PM KST
44.79%
Market Cap 287.73B
Revenue (ttm) 23.74B
Net Income (ttm) -11.07B
Shares Out 11.31M
EPS (ttm) -1,016.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 236,042
Average Volume 426,141
Open 26,600
Previous Close 26,850
Day's Range 25,500 - 26,600
52-Week Range 12,800 - 37,600
Beta 1.29
RSI 47.69
Earnings Date Aug 14, 2025

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 96
Stock Exchange KOSDAQ
Ticker Symbol 138610
Full Company Profile

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.

Financial Statements

News

There is no news available yet.